{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:35:41Z","timestamp":1782711341968,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T00:00:00Z","timestamp":1524268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00345-018-2283-x","type":"journal-article","created":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T02:49:52Z","timestamp":1524278992000},"page":"1449-1453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Urologists\u2019 attitudes to sexual complications of LUTS\/BPH treatments"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2133-5419","authenticated-orcid":false,"given":"Simone","family":"Giona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,21]]},"reference":[{"key":"2283_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003495-200666030-00002","volume":"66","author":"MM Dijk van","year":"2006","unstructured":"van Dijk MM, de la Rosette JJ, Michel MC (2006) Effects of alpha (1)-adrenoceptor antagonists on male sexual function. Drugs. 66:287\u2013301","journal-title":"Drugs."},{"key":"2283_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.eururo.2008.10.037","volume":"55","author":"CG Roehrborn","year":"2009","unstructured":"Roehrborn CG, Siami P, Barkin J et al (2009) The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study. Eur Urol. 55:461\u2013471","journal-title":"Eur Urol."},{"key":"2283_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","volume":"60","author":"CG Roehrborn","year":"2002","unstructured":"Roehrborn CG, Boyle P, Nickel JC et al (2002) Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 60:434\u2013441","journal-title":"Urology."},{"key":"2283_CR4","doi-asserted-by":"crossref","unstructured":"Roehrborn CG, Siami P, Barkin J et al (2008) The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 179:616\u2013621 (discussion 621)","DOI":"10.1016\/j.juro.2007.09.084"},{"key":"2283_CR5","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD McConnell","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 349:2387\u20132398","journal-title":"N Engl J Med."},{"key":"2283_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","volume":"57","author":"CG Roehrborn","year":"2010","unstructured":"Roehrborn CG, Siami P, Barkin J et al (2010) The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 57:123\u2013131","journal-title":"Eur Urol"},{"key":"2283_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinthera.2007.01.018","volume":"29","author":"MJ Naslund","year":"2007","unstructured":"Naslund MJ, Miner M (2007) A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate. Clin Ther 29:17\u201325","journal-title":"Clin Ther"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1464-410x.1999.00908.x","volume":"83","author":"S Madersbacher","year":"1999","unstructured":"Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int. 83:227\u2013237","journal-title":"BJU Int."},{"key":"2283_CR9","unstructured":"McConnell JD BM, Bruskewitz RC. Benign prostatic hyperplasia: diagnosis and treatment. In: (AHCPR) AfHCPaR (ed), vol 81994."},{"key":"2283_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1464-410X.1996.88213.x","volume":"77","author":"M Emberton","year":"1996","unstructured":"Emberton M, Neal DE, Black N et al (1996) The effect of prostatectomy on symptom severity and quality of life. Br J Urol 77:233\u2013247","journal-title":"Br J Urol"},{"key":"2283_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.urology.2007.09.017","volume":"71","author":"K Horasanli","year":"2008","unstructured":"Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C (2008) Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70\u00a0mL: a short-term prospective randomized trial. Urology 71:247\u2013251","journal-title":"Urology"},{"key":"2283_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.eururo.2007.11.044","volume":"54","author":"G Alivizatos","year":"2008","unstructured":"Alivizatos G, Skolarikos A, Chalikopoulos D et al (2008) Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas > 80 ml: 12-mo results of a randomized prospective study. Eur Urol. 54:427\u2013437","journal-title":"Eur Urol."},{"key":"2283_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/end.2006.20.580","volume":"20","author":"DM Bouchier-Hayes","year":"2006","unstructured":"Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ (2006) KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20:580\u2013585","journal-title":"J Endourol"},{"key":"2283_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.eururo.2006.04.003","volume":"50","author":"R Naspro","year":"2006","unstructured":"Naspro R, Suardi N, Salonia A et al (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up. Eur Urol. 50:563\u2013568","journal-title":"Eur Urol."},{"key":"2283_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0022-5347(05)00983-3","volume":"175","author":"A Briganti","year":"2006","unstructured":"Briganti A, Naspro R, Gallina A et al (2006) Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 175:1817\u20131821","journal-title":"J Urol."},{"key":"2283_CR16","doi-asserted-by":"crossref","unstructured":"Tabatabaei S, Choi B, Muir G. 2272 Ejaculation-preserving photoselective vaporization of prostate (EP-PVP): six years experience from a multi-centre study. J Urol 185:e910\u2013e911","DOI":"10.1016\/j.juro.2011.02.2515"},{"key":"2283_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ijir.2014.22","volume":"27","author":"M Kim","year":"2015","unstructured":"Kim M, Song SH, Ku JH, Kim HJ, Paick JS (2015) Pilot study of the clinical efficacy of ejaculatory hood sparing technique for ejaculation preservation in Holmium laser enucleation of the prostate. Int J Impot Res 27:20\u201324","journal-title":"Int J Impot Res"},{"key":"2283_CR18","doi-asserted-by":"crossref","unstructured":"Bruskewitz R, Issa MM, Roehrborn CG et al (1998) A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 159:1588\u20131593 (discussion 1593\u20131584)","DOI":"10.1097\/00005392-199805000-00048"},{"key":"2283_CR19","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/01.ju.0000127761.87421.a0","volume":"171","author":"B Hill","year":"2004","unstructured":"Hill B, Belville W, Bruskewitz R et al (2004) Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 171:2336\u20132340","journal-title":"J Urol."},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/08927790360587432","volume":"17","author":"E Cimentepe","year":"2003","unstructured":"Cimentepe E, Unsal A, Saglam R (2003) Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18\u00a0months. J Endourol\/Endourol Soc 17:103","journal-title":"J Endourol\/Endourol Soc"},{"key":"2283_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1464-410X.2011.10342.x","volume":"108","author":"HH Woo","year":"2011","unstructured":"Woo HH, Chin PT, McNicholas TA et al (2011) Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 108:82\u201388","journal-title":"BJU Int."}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2283-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T15:47:31Z","timestamp":1571240851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2283-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,21]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2283-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,21]]},"assertion":[{"value":"10 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Study funded by unrestricted educational grant from Neotract inc. Gordon Muir has received funding as investigator, consultant and mentor for both BSCI and Neotract.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"For this type of study, formal consent is not required","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}